Myrio Tx

Myrio Tx is at the forefront of biotechnology research, revolutionizing immuno-oncology with innovative approaches to antibody-based therapies. Located in Blackburn North, Victoria, at 6-16 Joseph Street, Myrio Tx is dedicated to enabling treatments that target intracellular components, such as mutated cancer-causing and viral proteins. The company’s pioneering protein-display system facilitates the discovery of antibodies against peptide-MHC complexes, significantly expanding the range of addressable cancer and viral targets.

With a focus on fully-human sequences, Myrio Tx’s discovered antibodies are adaptable for various applications, including CAR-T cell targeting, antibody-drug conjugates, bispecifics, and traditional antibodies. The company's platform is engineered to rapidly generate high-affinity and highly selective scFv antibody fragments, accelerating the evaluation and optimization of potential product candidates. Myrio Tx is committed to advancing the field through strategic partnerships and the development of an in-house portfolio of products.

Myrio Tx continues to drive innovation in biotechnology, promising a future where cancer has fewer places to hide. The company's commitment to research and development positions it as a key player in the next generation of immunotherapies. We invite the management of Myrio Tx to enhance your company’s visibility and commercial opportunities by creating a customized and exclusive company showcase and product listing on our platform.